Recognizing the Signs and Symptoms of Multiple Myeloma in the Primary Care Setting

You need to be logged in to continue. Please Log In or Register using the box at the top right of this page.

Release Date: October 25, 2013
Expiration Date: October 25, 2014

Expected time to complete this activity as designed: 45 minutes
There are no fees for participating in or receiving credit for this online activity.

Program Overview

Primary care physicians are most often the first to recognize the signs and symptoms of cancer, provide a preliminary diagnosis, and refer patients to oncology specialists. However, a significant number of multiple myeloma patients experience delay in diagnosis and, therefore, also experience delayed treatment. Early recognition and referral of multiple myeloma patients before they have significant disease burden is especially important as it has been demonstrated to translate into improved patient outcomes. Presenting a challenge, multiple myeloma patients often present with symptoms that are non-specific in nature. Furthermore, no single test will provide a diagnosis of multiple myeloma, thus primary care physicians must be able to navigate the differential diagnosis of this malignancy. This activity will focus on key symptoms and signs which, when presented to the primary care or internal medicine clinician, may trigger further investigation of multiple myeloma in the primary care setting. This activity will highlight common symptoms, what is the current standard of care in the assessment process, and what diagnostic tools are available to aid in the diagnosis.

Target Audience

This activity is designed for primary care physicians who have an interest in enhancing their clinical skills in recognizing the signs and symptoms of multiple myeloma in primary care.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Recognize the common symptoms, frequency of presenting features, risk factors, and demographics of patients with multiple myeloma
  • Recall NCCN and IMWG recommended diagnostic tests for multiple myeloma including considerations for their strengths and limitations, and their interpretation in making a differential diagnosis of this disease

Agenda

Recognizing Signs and Symptoms of Multiple Myeloma in the Primary Care Setting – Edward A. Stadtmauer, MD, and Craig Wynne, MD

Instructions for Participation and Credit

This activity is eligible for credit through October 25, 2014. After this date, this activity will expire and no further credit will be awarded.

  1. Read the target audience, learning objectives, and faculty disclosures.
  2. You may be asked to complete a short pre-test before accessing the educational content. This must be completed in order to move forward in the activity.
  3. Complete the educational content as designed.
  4. Complete the post-test. To receive a certificate, you must receive a passing score of 70%.
  5. Complete the activity evaluation survey to provide feedback and information useful for future programming.
  6. Certificates may be printed immediately after successfully completing the post-test and activity evaluation.

Faculty Biographies

Edward A. Stadtmauer, MD
Chief, Hematologic Malignancies
Abramson Cancer Center
University of Pennsylvania
Philadelphia, Pennsylvania

Dr. Edward Stadtmauer completed his medical degree at the University of Pennsylvania School of Medicine, and served his internship and residency in internal medicine at Albert Einstein College of Medicine, Bronx, New York. He completed his fellowship in hematology-oncology at the University of Pennsylvania where he is currently chief of the Hematologic Malignancies Section of the Abramson Cancer Center.

Board certified in internal medicine, hematology, and medical oncology, Dr. Stadtmauer is a reviewer for numerous journals and is on the editorial board of the Journal of Clinical Oncology. He is widely published on the subjects of acute and chronic leukemia, autologous bone marrow transplantation, and multiple myeloma. Dr. Stadtmauer’s writings have appeared in peer-reviewed journals such as Annals of Internal Medicine, Blood, Bone Marrow Transplantation, Journal of Clinical Oncology, and The New England Journal of Medicine, among others.

Craig S. Wynne, MD
Assistant Professor of Clinical Medicine
Edward S. Cooper Internal Medicine
University of Pennsylvania
Philadelphia, Pennsylvania

Dr. Craig Wynne received his medical degree from Albert Einstein College of Medicine, Bronx, New York. He completed his internship, residency, and fellowship at Graduate Hospital, Philadelphia. Dr. Wynne is currently assistant professor of clinical medicine and lead physician, E.S. Cooper Practice, at the University of Pennsylvania. He is certified by the American College of Physicians.

Accreditation

MediCom CME CREDIT
Accreditation Statement: MediCom Worldwide, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation Statement: MediCom Worldwide, Inc. designates this enduring material for a maximum of .75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure

As an organization accredited by the Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE) and California State Board of Registered Nursing, MediCom Worldwide, Inc. requires everyone who is a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest. Accordingly, the following disclosures were made.

Faculty Disclosures

Dr. Edward Stadtmauer has received honoraria related to speakers’ bureau activities from Celgene Corporation, Millennium Pharmaceuticals, Inc. (A wholly-owned subsidiary of Takeda Pharmaceutical Company Limited), and Onyx.

Dr. Craig Wynne has disclosed no relevant financial relationships.

Planning Committee Disclosures

The individuals listed below from MediCom Worldwide, Inc. reported the following for this activity: Joan Meyer, RN, MHA, executive director, and Eugene R. Tombler, PhD, FACME, medical director, oncology, have no relevant financial relationships.

Peer Reviewer Disclosure

In accordance with MediCom Worldwide, Inc. policy, all content is reviewed by external independent peer reviewers for balance, objectivity and commercial bias. The peer reviewers have no relevant financial relationships to disclose.

Off-Label Disclosures/Investigational Disclosures

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.

Dr. Stadtmauer has indicated that he does intend to discuss off-label uses of drugs, mechanical devices, biologics or diagnostics approved by the US Food and Drug Administration (FDA) for use in the US.

Dr. Stadtmauer has indicated that he does intend to discuss investigational drugs, mechanical devices, biologics or diagnostics not approved by the FDA for use in the US.

Dr. Wynne has indicated that he does not intend to discuss off-label uses of drugs, mechanical devices, biologics or diagnostics approved by the US Food and Drug Administration (FDA) for use in the US.

Dr. Wynne has indicated that he does not intend to discuss investigational drugs, mechanical devices, biologics or diagnostics not approved by the FDA for use in the US.

Hardware/Software/Internet Requirements

MediCom Worldwide, Inc. requires Internet Explorer® version 9.0 or higher, the latest version of Google Chrome, or the latest version of Safari, a computer running Windows® Vista, Windows® 7, or Mac OS X, 512MB of RAM or greater, 1.5 GHZ or faster processor, and a screen resolution of 1024x768 or higher. Certain educational activities may require additional software to view. These activities will be marked with the information and/or links to the required software. That software may include Adobe® Flash® Player, Adobe® Acrobat®, Windows Media® Player, and/or Microsoft® Silverlight™.

If you have any questions or concerns regarding this activity, please contact MediCom Worldwide, Inc. at 1-800-408-4242 or email us at info@managingmyeloma.com.

Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from The Binding Site. .

©2013 MediCom Worldwide, Inc., 101 Washington St., Morrisville, PA 19067, 800-408-4242.
No portion of this material may be copied or duplicated without the expressed permission of MediCom Worldwide, Inc.

You need to be logged in to continue. Please Log In or Register using the box at the top right of this page.